Trakeitis Bakterialis

01Pathophysiology

Bacterial tracheitis, also called membranous croup or pseudomembranous croup, is an acute bacterial infection of the subglottic trachea. The disease almost always develops as a secondary bacterial superinfection following a primary viral upper respiratory tract infection, most commonly parainfluenza virus (the same pathogen that causes viral croup). The preceding viral illness damages the tracheal mucosal epithelium, disrupts the normal mucociliary clearance mechanism, and creates an environment conducive to bacterial colonization.

Once bacteria (most frequently Staphylococcus aureus) invade the damaged mucosa, a vigorous inflammatory response ensues. The hallmark pathological finding is the formation of pseudomembranes, which are thick, adherent layers composed of fibrin, inflammatory exudate, necrotic epithelial debris, and bacterial colonies lining the tracheal wall. These pseudomembranes, combined with copious thick purulent secretions, progressively narrow the already small pediatric airway.

This is why the patient initially looks like viral croup but then acutely decompensates. The viral phase produces the classic barking cough and stridor due to subglottic edema. However, when bacterial superinfection takes hold, the child develops high-grade fever and a toxic appearance that is disproportionate to what would be expected in simple croup. The stridor worsens and, critically, does not improve with nebulized racemic epinephrine or corticosteroids, because the obstruction is not primarily from edema but from thick secretions and pseudomembranes physically occluding the airway.

The reason this condition is dangerous lies in the mechanical nature of the obstruction. Unlike croup, where edema can be pharmacologically reduced, the pseudomembranes and tenacious secretions cannot be reversed with medications alone. Fragments of pseudomembrane can also dislodge and cause acute, complete airway obstruction, making this a true airway emergency requiring intervention.

02Classification and Clinical Manifestation

Bacterial tracheitis does not have a formal classification system. However, the clinical course can be divided into phases that are important for exam recognition:

Clinical Manifestation

03Diagnostic Workup

The best initial test is a lateral neck radiograph. The test writer places this as the correct answer because it is noninvasive and can be performed rapidly. The classic finding is an irregular or "shaggy" tracheal contour on the lateral view, which represents pseudomembranes and mucosal irregularity projecting into the airway lumen. This is the key radiographic discriminator from viral croup, where the tracheal wall appears smooth even though both conditions share subglottic narrowing (steeple sign) on the AP view.

Other radiographic clues include a distended hypopharynx (from air trapping above the obstruction) and intraluminal soft tissue densities within the trachea, representing detached pseudomembrane fragments.

The most accurate test is direct laryngoscopy or bronchoscopy, which confirms the diagnosis by directly visualizing the pseudomembranes and purulent secretions adherent to the tracheal mucosa. This also serves a therapeutic purpose, as it allows suctioning of secretions and debridement of pseudomembranes to relieve obstruction. In practice, this is performed in a controlled setting (operating room or ICU) with preparation for potential intubation.

Laboratory studies are supportive but not diagnostic. The CBC typically shows leukocytosis with a left shift, consistent with bacterial infection. Blood cultures are obtained but are frequently negative (positive in roughly 10% of cases). Tracheal aspirate cultures obtained during laryngoscopy are the most reliable method for identifying the causative organism and guiding antibiotic therapy.

A point to note for exam purposes: the lateral neck X-ray in epiglottitis shows a thumbprint sign (swollen epiglottis), while in bacterial tracheitis the epiglottis appears normal and the pathology is at the subglottic/tracheal level.

04Management and Treatment

The first priority is securing the airway. Unlike viral croup, where nebulized racemic epinephrine and systemic corticosteroids are effective, these interventions do not provide meaningful relief in bacterial tracheitis because the obstruction is caused by pseudomembranes and purulent secretions rather than mucosal edema alone. The failure of standard croup management is itself a diagnostic clue.

A large proportion of children with bacterial tracheitis require endotracheal intubation for airway protection. A key exam-testable detail: use an endotracheal tube 0.5 to 1.0 mm smaller than the age-calculated size to accommodate the tracheal swelling and avoid further mucosal trauma. Once intubated, frequent tracheal suctioning is essential to clear the thick secretions and pseudomembrane fragments that can occlude even an artificial airway.

Empiric IV antibiotics should cover the most common pathogen, Staphylococcus aureus, including MRSA. The standard regimen is vancomycin combined with a third-generation cephalosporin (such as ceftriaxone) to provide broad coverage against other organisms like H. influenzae, S. pneumoniae, and M. catarrhalis. Once culture and sensitivity data return from the tracheal aspirate, the regimen is narrowed accordingly.

Corticosteroids are generally not considered the primary treatment, though some clinicians use them adjunctively. The test answer will not list steroids as the correct management for bacterial tracheitis; this is a deliberate contrast with viral croup where dexamethasone is first-line.

Patients should be admitted to an ICU given the risk of sudden airway compromise. The typical antibiotic course is 10 to 14 days, with transition to oral antibiotics when the child is clinically improving, afebrile, and extubated. Most children improve within 3 to 7 days with appropriate treatment, and mortality with modern management is low.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students get questions on bacterial tracheitis wrong is by confusing it with either viral croup or epiglottitis. The test writer constructs the vignette to have an initial presentation that looks exactly like croup, then introduces a clinical pivot: the child suddenly worsens, develops a high fever, appears toxic, and fails to improve with nebulized epinephrine. Students who do not recognize this biphasic clinical course (viral prodrome followed by acute bacterial deterioration) will incorrectly select croup as the answer and choose nebulized epinephrine as the next step, which is the trap.

The second common error is selecting epiglottitis. Both conditions present with high fever, stridor, and a toxic-appearing child. The discriminator is that epiglottitis features drooling, dysphagia, and absence of a barking cough, while bacterial tracheitis features a barking cough, no drooling, no dysphagia, and the ability to lie flat. On imaging, epiglottitis shows the thumbprint sign, while bacterial tracheitis shows a normal epiglottis with an irregular, ragged tracheal wall.

A third trap involves management. Students may select dexamethasone as the treatment, carrying over the reflex from croup management. The correct answer is IV antibiotics with anti-staphylococcal coverage and airway management, not steroids.

The core competency being tested is the ability to recognize that a child with croup who acutely worsens and fails standard therapy has progressed to bacterial tracheitis, and that the management shifts from pharmacologic airway management (epinephrine and steroids) to antibiotics, suctioning, and intubation preparedness. This tests the student's understanding of a clinical escalation pattern and the distinction between obstructive pathologies driven by edema versus those driven by purulent secretions and pseudomembranes.